Philippines at a glance
- Population
- 116.8 million 2025
- Life expectancy at birth
- 69.9 years, 2024
- People aged 65 and over
- 5.7 % of people, 2025
- Health spending per person
- 194 US$ per person, 2023
- Doctors
- 0.79 per 1,000 people, 2021
Updated
Reviewed by Vidhi Upadhyay
Philippines Chronic Urticaria Treatment Market Industry Trends and Forecast to 2034: Segmented by (Drug Class, Type, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$8.4 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $7.4 Mn | — | — |
| 2025 (base) | $8.0 Mn | +$0.6 Mn | — |
| 2026 (forecast) | $8.6 Mn | +$0.7 Mn | +8.3% |
| 2027 (forecast) | $9.4 Mn | +$0.7 Mn | +17.3% |
| 2028 (forecast) | $10.1 Mn | +$0.8 Mn | +27% |
| 2029 (forecast) | $11.0 Mn | +$0.8 Mn | +37.6% |
| 2030 (forecast) | $11.9 Mn | +$0.9 Mn | +49% |
| 2031 (forecast) | $12.9 Mn | +$1.0 Mn | +61.4% |
| 2032 (forecast) | $13.9 Mn | +$1.1 Mn | +74.7% |
| 2033 (forecast) | $15.1 Mn | +$1.2 Mn | +89.2% |
| 2034 (forecast) | $16.3 Mn | +$1.3 Mn | +105% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $8.0 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $16.3 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 8.3% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Drug class, type and end user (see all) |
| Key players | Novartis AG, Sanofi, Regeneron Pharmaceuticals, Celldex Therapeutics, Roche (see all) |
| Regulator in the Philippines | FDA PhilippinesSource: Food and Drug Administration Philippines. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Chronic urticaria treatments control long-lasting hives and itching that do not go away with standard antihistamines.
Key segments of the chronic Urticaria Treatment market include drug class (Antihistamines, Anti-IgE Biologics and BTK Inhibitors) and type (Chronic Spontaneous Urticaria and Chronic Inducible Urticaria).
More people diagnosed with immune diseases, strong results from biologics and oral targeted drugs, and earlier treatment are driving the chronic Urticaria Treatment market. Biosimilars are widening access.
New targets, oral drugs that replace injections and cell therapies for autoimmune disease give the chronic Urticaria Treatment market room to grow.
High prices, infection risks with immune-suppressing drugs, patent expiries and the need for long-term treatment hold back the chronic Urticaria Treatment market.
The chronic Urticaria Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Drug products need registration with the Food and Drug Administration of the Philippines (FDA).[1] PhilHealth is the national health insurer, and the Universal Health Care Act of 2019 makes every Filipino a member.[2]
[1] Food and Drug Administration Philippines. Checked 14 Nov 2026.
[2] PhilHealth. Checked 14 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for chronic Urticaria Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Philippines.
What doctors and scientists are doing in Chronic Urticaria Treatment right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.
From our blog
Philippines · 2 shared keywords
Philippines · 1 shared keyword
Philippines · 1 shared keyword
Philippines · 1 shared keyword
Philippines · 1 shared keyword
Philippines · 1 shared keyword
Medical Devices · Philippines
Digital Health · Philippines
Medical Devices · Philippines
Healthcare Services · Philippines
OTC & Nutraceuticals · Philippines
OTC & Nutraceuticals · Philippines